Risks and benefits of multiple sclerosis therapies: need for continual assessment? : Current Opinion in Neurology

Secondary Logo

Journal Logo

Demyelinating diseases: Edited by Hans-Peter Hartung

Risks and benefits of multiple sclerosis therapies: need for continual assessment?

Kieseier, Bernd Ca; Wiendl, Heinzb; Hartung, Hans-Petera; Leussink, Verena-Isabella; Stüve, Olafc,d

Author Information
Current Opinion in Neurology 24(3):p 238-243, June 2011. | DOI: 10.1097/WCO.0b013e32834696dd

Abstract

© 2011 Lippincott Williams & Wilkins, Inc.

You can read the full text of this article if you:

Access through Ovid